Variant report
Variant | esv3326795 |
---|---|
Chromosome Location | chr2:213208003-213208395 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr2:213202563..213204297-chr2:213206010..213208677,2 | K562 | blood: |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs372398217 | chr2:213208004-213208005 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs540634067 | chr2:213208036-213208037 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs560083233 | chr2:213208040-213208041 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs532295708 | chr2:213208047-213208048 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs145049867 | chr2:213208077-213208078 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs562378380 | chr2:213208101-213208102 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs573860782 | chr2:213208114-213208115 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs531524816 | chr2:213208116-213208117 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs373467886 | chr2:213208146-213208147 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs367586297 | chr2:213208162-213208163 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs192954689 | chr2:213208221-213208222 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs6754674 | chr2:213208256-213208257 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs533611276 | chr2:213208289-213208290 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs547429117 | chr2:213208292-213208293 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs34672853 | chr2:213208296-213208297 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs570432138 | chr2:213208309-213208310 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs539367079 | chr2:213208334-213208335 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs184981352 | chr2:213208359-213208360 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ependymoma | 16718352 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Breast cancer | 17603634 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Breast cancer | 16272173 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Autism | 16446308 | CNVD |
Autism | 19401682 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Lung cancer | 18438408 | CNVD |
Prostate cancer | 18632612 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Cervical cancer | 21062161 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Non-muscle invasive bladder neoplasm | 19445696 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Autism | 20808228 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Ovarian cancer | 19193619 | CNVD |
Non-small cell lung cancer | 18676828 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Chordoma | 18071362 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Schizophrenia | 18923514 | CNVD |
Schizophrenia | 22241247 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Urothelial cell carcinoma | 18451213 | CNVD |
Developmental delay | 21147756 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Schizophrenia | 18990708 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:213201800-213213000 | Weak transcription | Aorta | Aorta |
2 | chr2:213205600-213221000 | Weak transcription | H9 Derived Neuron Cultured Cells | ES cell derived |
3 | chr2:213208000-213210800 | Enhancers | Fetal Heart | heart |